D. Soto-Castro et al.
Steroidsxxx(xxxx)xxx–xxx
anesthetic, sedative or hypotensive properties. Nonetheless, the synth-
esis of them implied several hours or days under reflux in the corre-
sponding amine. These types of compounds were reinvestigated by
Anderson et al., where the proposed methodology greatly reduces the
time reaction to 4.5 h at 120–130 °C in ethylene glycol [11].
2.2. General procedure for the synthesis of sulfated zirconia
The SZ was synthesized as previously reported by Negrón et al. [16].
Zirconium n-propoxide (20 mL, 70% n-propanol) was mixed with n-
propanol (30 mL) and stirred with a magnetic bar. Then, an acid so-
lution (1 mL 98% sulfuric acid in 3.2 mL of distilled water) was added
dropwise in order to cause the hydrolysis and gelation of the zirconium
n-propoxide. The solid was filtered and dried at 80 °C until complete
alcohol evaporation, then calcinated in air at 600 °C for 6 h.
Recently, de Medina et al. [12] reported the potent biological
properties of a set of products obtained by catalytic aminolysis of 5,6α-
epoxy-cholesterol with different polyamines. In the anticancer line, 5α-
hydroxy-6β-[2-(1H-imidazol-4-yl)ethylamino]cholestan-3β-ol known
as dendrogenin A is a β-aminoalcohol that, at a nanomolar concentra-
tion, induces the dead of tumor cell lines of metastatic melanoma and
breast cancer. Additionally, Poirot’s group showed [13] that den-
drogenin A is a natural metabolite occurring in mammals as an enzy-
matic product of the conjugation of 5,6α-epoxycholesterol and hista-
mine. Its activity, as tumor suppressor metabolite, was found to be
related to the selective inhibition of cholesterol epoxide hydrolase and
it triggered tumor re-differentiation and growth control in mice, and
hence it improved animal survival. Although these compounds could be
natural, they were synthesized by regioselective aminolysis of 5,6α-
epoxycholesterol with lithium perchlorate in anhydrous ethanol under
In this context, the classical synthesis to obtain β-aminoalcohols [14]
involves epoxide aminolysis at high temperatures, the use of expensive
chemicals, long reaction times, and usually high selectivity is difficult to
attain, as described before. Because of this, the research has been directed to
remedying these problems using solid catalysts. In this context, sulfated
zirconia has received much attention as solid catalyst, due to its acid and
basic catalytic properties and because the reactions can be carried out under
solvent free conditions avoiding environmental problems. For this purpose,
sulfated zirconia (SZ) has been used in selective epoxide aminolysis, a
methodology showing experimental simplicity, solvent free and mild reac-
tion conditions. Also, SZ is an inexpensive and reusable catalyst that pro-
vides products in high yields [15,16].
Several cell lines that originated from carcinomas of human patients
are available for use in basic studies of human cancer. Among them, the
MCF-7 cell line is used in apoptosis studies because it has a genetically
defective form of caspase 3, an important apoptosis- inducing effector
molecule [17]. MCF-7 is a stable epithelial cell line originally obtained
from the pleural effusion of a female patient with metastatic breast
cancer whose disease responded to hormone therapy. These cells have
substantial amounts of estrogen receptor [18].
Due to the wide range of biological activities that steroidal ami-
noalcohols have and taking in consideration the harsh condition and
long reaction times to obtain them, there is a need to implement novel
synthetic methodologies to obtain this kind of compounds. So, this
work was focused on the development of an alternative route for ami-
nolysis by using SZ, which provided selective α-epoxide cleavage
under solvent-free conditions making it environmentally friendly.
Additionally, in vitro antiproliferative activity was evaluated for β-
aminoalcohol derivatives from cholesterol 5 and diosgenin 6 against
MCF-7 cancer line by Crystal violet staining (CVS) and 3-(4,5-di-
methylthiazo-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays.
2.3. Synthesis of compounds
2.3.1. General procedure for the synthesis of steroidal epoxides
The compounds were prepared according to the protocols reported
by Yadav et al. [19] and de Medina et al. [12] with slight modifications.
To a 150 mL round-bottomed flask equipped with a magnetic stirrer,
were added 1.00 g of steroid and 20 mL of CH2Cl2. The solution was
poured onto an ice bath at 0
2 °C. Afterwards, 1.5 equivalents of m-
chloroperbenzoic acid (m-CPBA) were added and the reaction was
stirred 30 min. Crushed ice was added and the aqueous layer was ex-
tracted 3 times with CH2Cl2. The organic layer was washed with
NaHCO3 solution until pH 7 was reached, dried with Na2SO4 and
concentrated in vacuum.
2.3.1.1. 5,6α-Epoxy-5α-cholestan-3β-ol (3a):5,6β-epoxy-5β-cholestan-3β-
ol (3b). Cholesterol (1) (1.50 g, 3.88 mmol) was reacted with 1.00 g
(5.79 mmol) of m-CPBA according to the general procedure and 1.53 g
(3.79 mmol, 98%) of white solid product were obtained as a mixture of
isomers in a 5:1 ratio of α:β epoxides. The structure of the compounds
was confirmed by comparison with NMR data previously reported [12]
(S1.1).
2.3.1.2. (5,6α,25R)Epoxy-spirostan-3β-ol (4a):(5,6β,25R)epoxy-spirostan-3β-
ol (4b). Diosgenin (2) (1.50 g, 3.61 mmol) was reacted with 0.93 g
(5.41 mmol) of m-CPBA according to the general procedure and 1.49 g
(3.46 mmol, 96%) of white solid product were obtained as a mixture of
isomers in a 5:1 ratio of α to β epoxides. The structure of the compounds
was confirmed by comparison with NMR data previously reported [20,21]
(Supporting information S1.2).
2.3.2. General procedure for the synthesis of steroidal β-aminoalcohols
The steroidal mixture of α and β epoxides (5:1 ratio) and sulfated
zirconia (SZ, previously heated to 110 °C for 12 h), in a 2:1 wt ratio,
were placed in a 25 mL round-bottom flask, which was purged with N2.
Over these, 4 equivalents of aniline were added and the reaction was
stirred 6 h at 120 °C. Once the reaction was completed and room tem-
perature was reached, the mixture was diluted with CH2Cl2 and filtered
to recover the SZ. The crude product was purified by column chroma-
tography on silica gel using increasing polarity from hexane to hexane/
EtOAc.
2.3.2.1. 6β-Phenylamino-cholestan-3β,5α-diol (5). 300 mg (0.75 mmol)
of epoxide mixture (3a, 3b) were reacted with 0.27 mL (3.00 mmol) of
aniline catalyzed by 150 mg of SZ. After purification by column
chromatography (product 5 eluted with hexane/EtOAc 8:2), 298 mg
(0.60 mmol, 97%) of a white solid was obtained. m.p. 191.3–192.5 °C,
lit. m.p. 202 °C [22] FT-IR (ATR, cm−1): 3524 (NH); 3407 (OH); 2945
(CH). 1H NMR (500 MHz, CDCl3) δ (ppm)): 7.15 (2H, t, J = 7.8, H-29);
6.66 (1H, t, J = 7.3, H-31); 6.58 (2H, d, J = 7.9, H-30); 4.07 (1H, m, H-
3); 3.69 (1H, d, J = 8.5, H-NH); 3.35 (1H, s, H-6); 2.02 (2H, m, H-4);
1.22 (3H, s, H-19); 0.9 (3H, d, J = 6.4, H-21); 0.86 (3H, d, J = 6.4, H-
26); 0.85 (3H, d, J = 6.4, H-27); 0.68 (3H, s, H-18). 13C NMR
(126 MHz, CDCl3) δ (ppm): 147.8 (C-28); 129.4 (C-30 and C-32);
117.2 (C-31); 113.0 (C-29); 113.0 (C-33); 77.1 (C-5); 67.8 (C-3); 59.5
(C-6); 56.3 (C-17); 55.9 (C-14); 46.0 (C-9); 43.8 (C-13); 41.8 (C-4); 39.6
(C-24); 40.0 (C-12); 38.8 (C-10); 36.2 (C-22); 35.9 (C-20); 31.8 (C-1);
2. Experimental
2.1. General
All chemicals were obtained from commercial sources. Unless stated
otherwise, these were used without further purification. CH2Cl2 was
dried by distillation over CaH2. NMR spectra were recorded on a JEOL
ECA+500 instrument in CDCl3 as solvent. Chemical shifts are reported
in parts per million (ppm) and coupling constants are expressed in Hz.
Mass spectra were recorded with an Agilent Technologies MS TOF using
the ESI (+) technique. The absorbance of 96-well plates for crystal
violet and MTT was determined in a plate reader (Thermo Scientific,
USDA) at 595 and 570 nm, respectively.
2